Xiangyang Liu

Dr. Liu is the General Manager of Guangdong Youyuan Bioengineering Co., Ltd. He graduated from Shandong University School of Medicine with a major in clinical medicine. He received a master's degree from Peking Union Medical College and Doctorate degree in tumor biology from Wayne State University, USA. He has more than 30 years of basic and clinical research experience, and his research areas include but not limited to cancer immunology, transplantation immunity, pharmacology, biochemistry, microbiology, molecular biology, and so on. He has extensive work experience in regenerative medicine, and has participated in the cell therapy project of the University of Chicago as the chief scientific officer; participated in or led a number of clinical trials of therapeutic drugs and stem cells. Dr. Liu served as Chairman of the Midwest Branch of SAPA during 2012-2013, and as a reviewer for various journals including American Cancer Society, Diabetes Society, DIA member. Dr. Liu has the experience of successfully establishing and operating and managing several enterprises. He has served as the President of Living Spring Comprehensive Consulting Co, Ltd, Vice President of Eight Rivers Management Co., Ltd., Vice President of Q2 Intelligence Co., Ltd., General Manager of the Hong Kong International Regenerative Center, and CEO and Chief Scientific Officer of the China Regenerative Medicine International Co. Ltd.